11-56989272-T-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001005323.1(OR5AK2):c.359T>A(p.Val120Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000124 in 1,613,980 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001005323.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR5AK2 | NM_001005323.1 | c.359T>A | p.Val120Glu | missense_variant | 1/1 | ENST00000326855.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR5AK2 | ENST00000326855.3 | c.359T>A | p.Val120Glu | missense_variant | 1/1 | NM_001005323.1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152216Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000398 AC: 10AN: 250980Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135614
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461764Hom.: 0 Cov.: 34 AF XY: 0.00000550 AC XY: 4AN XY: 727182
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152216Hom.: 0 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74368
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 06, 2022 | The c.359T>A (p.V120E) alteration is located in exon 1 (coding exon 1) of the OR5AK2 gene. This alteration results from a T to A substitution at nucleotide position 359, causing the valine (V) at amino acid position 120 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at